Stockreport

IGC Pharma Reports Third Quarter Fiscal 2024 Results

IGC Pharma, Inc.  (IGC) 
NASDAQ:AMEX Investor Relations: igcinc.us/investor-center/overview
PDF POTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the third fiscal quarter of 2 [Read more]